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Hazards of ionising radiation: 100 years of observations on man*
Sir Richard Doll
Imperial Cancer Research Fund Cancer Studies Unit, Harkness Building, Radcliffe Infirmary, Oxford OX2 6HE, UK.
Summary In November 1895, when Conrad Rontgen serendipitously discovered X-rays, epidemiology was
effectively limited to the study of infectious disease. What little epidemiological work was done in other fields
was done as part of clinical medicine or under the heading of geographical pathology. The risks from exposure
to X-rays and subsequently from other types of ionising radiation were consequently discovered by qualitative
association or animal experiment. They did not begin to be quantified in humans until half a century later,
when epidemiology emerged as a scientific discipline capable of quantifying risks of non-infectious disease and
the scientific world was alerted to the need for assessing the effects of the radiation to which large populations
might be exposed by the use of nuclear energy in peace and war.
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Early observations
Acute tissue damage
R6ntgen's (1895) discovery was published in what would now
be regarded as the miraculously short time of 1 week. Many
people began to experiment with the new tool and it was
quickly found that the rays could damage biological tissue.
Within 3 months, one experimenter produced a bald patch by
trying to detect a coin through his head (Daniel, 1896); a
month later Thomas Edison, the inventor of the incandescent
electric lamp and so much else, complained that his eyes were
sore and red after prolonged experiments (Burrows, 1986);
and after another 2 months Stevens (1896) reported the
production of a painful erythema of the skin. Before a year
had passed, many workers had experienced burns of the
hands and systemic effects had begun to be recognised. One
man, who had experienced several attacks of dermatitis,
developed a high fever, languor, diarrhoea and vomiting, and
another, whose experiments involved exposing his abdomen
for 2 hours a day, complained of abdominal pain and
tenderness and diarrhoea, which cleared after a fortnight in
the country, recurred when he resumed his experiments, and
disappeared after he shielded his body with lead (Walsh
1897).
The cause of the damage was debated for several years.
Bowles was the first to suggest in print, in 1896, that the rays
themselves were responsible; but many, including Sylvanus
Thompson, first president of the Rontgen Society in Britain,
thought that it might be electric charges (Thompson, 1897).
Others thought that platinocyanides used in the fluorescent
screens, platinum particles from the tube, ultra-violet rays or
the formation of ozone in the tissues might be responsible
(Colwell and Russ, 1934). Conviction that the Rontgen rays
were the cause came only in 1900 with the results of
Kienbock's experiments on rats and their confirmation by
Rollins (1901) in Boston.
Production of cancer
Skin cancer Soon, more serious effects appeared. Four years
after Rontgen's discovery, squamous carcinomas began to
occur on the hands of workers that were already the site of
chronic dermatitis (Frieben, 1902). The tumours tended to be
highly malignant, presumably because continued exposure
after the initiation of a malignant clone led to its rapid
progression, and many of those affected died from the
disease. When, in 1936, the German Rontgen Society erected
a monument to the memory of those who had died as a
result of their work, 169 names were recorded on it (Meyer,
1937) and a further 191 were added in a supplementary list in
1959 (Holthusen et al., 1959 - although Holthusen et al.
refer only to an additional 190, the names listed add up to
360). These 'radiation martyrs', as they were called (though
victims would have been a better term as they did not know
beforehand what might happen to them) came from the 22
countries listed in Table I. France tops the list with 65
names, closely followed by Germany with 59 and the US
with 55.
Causes of death on the original list were given for all but
the 39 US martyrs. Three-quarters were attributed to skin
cancer (96/130) and the others to anaemia (18), leukaemia
(two), accidents (six) and a variety of causes (eight), ranging
from asthenia to chest burns from the transport of radium.
Leukaemia Whether leukaemia could be attributed to radia-
tion remained controversial for many years. In 1911 von
Jagic et al. reported four cases following prolonged exposure
and several more were recorded in the next 20 years. Then
Aubertin (1931) reported seeing five radiologists with myeloid
leukaemia in a period when he had seen the disease in only
one non-radiological physician, which led him to conclude
that myeloid leukaemia was particularly common in
radiologists. A year later, however, Nielsen (1932) could still
find records of only 14 acceptable cases in radiation workers
in the literature and when, in 1934, Colwell and Russ
reviewed the injuries attributable to X-rays and radium they
could not decide whether leukaemia should be included. In
the same year Marie Curie died of chronic myeloid
leukaemia; but it was another 10 years before any
epidemiological evidence stronger than Aubertin's (1931) was
obtained. Then March (1944) matched the list of members of
the American Roentgen Ray Society with the death notices in
the Journal of the American Medical Association and two
radiological journals and found that 4.57% of 173 with
known causes were attributed to leukaemia against 0.44% of
over 50 000 deaths from known cause among non-radio-
logical physicians recorded in the Medical Association Jour-
nal. The 10-fold difference was statistically highly significant;
but, despite the fact that Furth (1934) had already demon-
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Table I Numbers of radiation martyrs by country of origin (Meyer, 1937; Holthusen et al.,
1959)
France 65 Russia 13 Australia 2
Germany 59 Hungary 11 Finland 2
USA 55 Austria 8 Israel 2
UK 42 Switzerland 7 Portugal 2
Italy 29 Belgium 5 Dutch East Indies I
Japan 28 Denmark 5 Greece I
Czechoslovakia 17 Spain 4 Poland I
Yugoslavia I
strated that irradiation could produce leukaemia in animals,
March concluded only that 'If .... a relationship exists
between prolonged exposure to radiation and the develop-
ment of leukaemia, then the fact that a certain percentage of
non-radiological physicians are exposed to radiation would
tend to increase the validity of the attempted demonstration.'
Lung Cancer Other cancers that came to be recognised as
caused by occupational exposure were cancers of the lung
and bone. The first occurred in the miners of Schneeberg and
Joachimsthal in the Harz mountains. The mines had been
worked for 500 years and the miners had long been known to
have a high mortality from a chest disease, called simply
mountain sickness. In 1879, Harting and Hesse showed it
was cancer, but they called it a lymphosarcoma. The excep-
tionally high prevalence of occupational cancer was recorded
by Arnstein (1913a,b), who corrected the histological diag-
nosis and found that 42% of deaths of miners between 1875
and 1912 were attributable to it. This high rate was
confirmed by Rostoski et al. (1926) who followed 154 miners
and ex-miners for 31 years. Twenty-one died and lung cancer
was confirmed at necropsy in 13. The mines had been worked
successively for silver, nickel, cobalt, bismuth, arsenic and
pitchblende before they provided the ore from which, 2 years
after R6ntgen's discovery, the Curies isolated radium, and
they went on to be mined for radium and eventually
uranium. The idea that the cancers might be due to radon
was proposed in 1921 by Margarete Uhlig, herself a native of
Schneeberg, who noted that she had seen the suggestion
made 'in an article by a layman'. Rajewsky's (1939)
measurements of the radioactivity in the air of the mines
averaged about 3liCi (I x 105Bq) m-3 and the attribution to
ionising radiation was commonly accepted. When, however,
Lorenz reviewed the evidence in 1944 he concluded that
radon was not the sole cause of the excess. Contributing
factors, he thought, might include pneumoconiosis, arsenic
and perhaps hereditary susceptibility.
Bone Sarcoma The role of radium in the production of
bone sarcoma in luminous dial painters was recognised more
quickly. Workers in a New Jersey factory had used a phos-
phorescent zinc sulphide paint, made luminous by the addi-
tion of small amounts of radium and mesothorium, and in
1925 Hoffman reported that 12 had persistent infections of
the jaw, sometimes with marked anaemia, from one or both
of which four had died. Six years later, Martland (1931)
reported 18 deaths from occupational disease among 800
young women who had been employed in the factory, all in
the small proportion who had worked there for more than 2
years. Most had severe anaemia but in five instances death
was due to sarcoma of the bone. Substantial amounts of
radium were present in their bones and Martland concluded
that the 27% of deaths attributable to sarcoma was so much
greater than the 0.1% or less recorded in autopsy series that
it provided 'overwhelming evidence that the radioactivity of
these dial painters is the true cause of the sarcoma'. Martland's
comparison was hardly fair, but the cancers all occurred in
bone that showed severe osteitis and the relationship was
inescapable.
Martland (1931) noted that McCombs and McCombs
(1930) had just advanced the hypothesis 'that cancer is due
primarily to mutation in a somatic cell caused, possibly, in
some instances by ionization' and he wondered whether
'some such agency is active in the greatly increased
prevalence of cancer' in the luminous dial painters. If it was,
he recognised that there was unlikely to be a threshold dose
below which no effect occurred and he suggested that 'some
other types ofmalignancy may be caused by minute amounts
of radioactive substance to which the human body, in its
normal environment, is exposed.'
Other cancers Other types of cancer were found to occur in
tissues that had been scarred as a result of heavy irradiation,
including cancers of the lip, larynx, pharynx, thyroid and
connective tissue. These occurred, for the most part, 20-40
years after radiotherapy, which had been given for thyrotox-
icosis, for tuberculosis affecting the skin, bones and cervical
glands, and (less often) for other cancers in neighbouring
sites. Proof that they were caused by radiation was lacking;
but causation was assumed because they occurred in sites
showing radiation scars in which cancer was not normally
common. In 1957, Cade could find less than 300 cases of all
types of cancer attributed to the use of radiotherapy in the
medical literature, including cancers of the skin; but he added
34 that had come under the care of three radiotherapists in
London and the actual total must have been much higher.
Genetic damage
The possibility that genetic damage might occur was recog-
nised very early from animal experiments, when Albers-
Schonberg (1903) in Hamburg demonstrated that X-rays
could damage rabbits' testes. It was not, however, until 1907
that transmissible genetic damage was reported, when
Bardeen, an anatomy professor at the University of Wiscon-
sin, produced congenital defects in toads by irradiation of the
parents' spermatazoa. Twenty years later, Muller (1927), a
zoologist at the University of Texas, showed that X-rays
could produce mutations in fruit flies and that the prevalence
of the effect was approximately linearly proportional to the
dose. No observation had been made on humans; but the
evidence for the production of hereditary mutations was held
to be of universal application and its applicability to humans
was not questioned.
Criteriafor protection
The recognition of the acute effects had led rapidly to the
introduction of techniques to reduce the direct exposure of
the operator and to limit the dispersal of the rays, once it
was recognised that the rays themselves were responsible.
The discovery of the possibility of damage to the testes
heightened concern and by 1905 the German Rontgen ray
expert who discovered the damage was 'encased from
Schnurrbart to foot in a veritable suit of armour' (Butcher,
1905). It was not, however, until the First World War, when
many new operators had to be recruited to provide the rapid
expansion of X-ray facilities required to deal with war
injuries, that the need was felt for codes of practice, as was
recommended by the Rontgen Society in Britain in 1915.
Little attention seems to have been paid to such informal
advice and it was superseded by the formal recommendations
of protection committees set up by the American Roentgen
Ray Society (1922) in 1920 and a group of concerned British
3
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scientists in 1921. The recommendations of the self-styled
British X-ray and Radium Protection Committee (1921) were
published first and were subsequently accepted with minor
modifications for international use by the second Congress of
Radiology in Stockholm in 1928 (International X-ray and
Radium Protection Committee, 1928). With the introduction
of a measure of dose in the same year, the recommended
limit of exposure was set at 1 rad per week in 1934, where it
remained until after the Second World War.
State of knowledge in mid-century
From 1928, until the explosion of the atomic bombs over
Hiroshima and Nagasaki, 3 months short of the 50th
anniversary of Rontgen's discovery, it was thought that
clinical experience aided by animal experimentation had
found a way to use ionising radiations safely, without caus-
ing an occupational hazard for the operator or long-term
side-effects for the patient. The acute effects and the risk of
progressive anaemia had been avoided or, in the case of
radiotherapy, kept within acceptable limits; the risk of caus-
ing cancer, which had not been accepted as caused by muta-
tions, was generally thought to have been avoided by
avoiding macroscopic damage to tissues (Gliicksmann, 1952);
and the genetic effect, which was accepted as due to muta-
tions and capable of being caused by any dose of ionising
radiations however small, could be kept to negligible levels
by protecting the gonads. Only March's (1944)
epidemiological observation, made a year before the exp-
losions, gave cause to think that any long-term effects might
still be being produced.
The impact of nuclear power
Establishment ofthe Atomic Bomb Casualty Commission
Following the atomic explosions, there was great public con-
cern about the possible effects that the radiation might have
had. By far the greatest proportion of the approximately
180 000 deaths was the direct result of blast and heat. Several
thousand of the immediate survivors, however, died shortly
afterwards as a result of acute radiation sickness and
thousands more experienced acute symptoms and recovered.
What might happen later to those who recovered was unc-
lear. It was recognised that knowledge of the long-term
effects of substantial amounts of whole-body irradiation was
incomplete and the joint commission of the US Army and
Navy, which visited Japan shortly after the war, recom-
mended a long-term study of the survivors to determine any
possible medical and biological effects. The proposal to set
up an Atomic Bomb Casualty Commission (ABCC) in con-
junction with the Japanese National Institute of Health was
approved by Truman in November 1946 and an ABCC office
was opened in January 1948 with long-term financial support
from the US Atomic Energy Commission. Large programmes
of research were initiated into the genetic and somatic effects
of radiation, as seen in the survivors of the two explosions,
and a new era was opened (Cannan, 1962).
The genetic programme under the direction of Neel and
Schull was epidemiological in character from the start, as it
set out to determine the prevalence of congenital anomalies,
the sex ratio at birth, stillbirth and neonatal death rates,
birthweights and anthropometric measurements in infancy
for all children born in the two cities. Data were collected by
research workers shortly after the births had occurred and a
supplementary questionnaire was completed by, and a blood
sample taken from, all mothers whose pregnancy terminated
abnormally and a 'random' 10% of all other mothers.
Autopsies were obtained for about half of all stillbirths and
neonatal deaths and a quarter of surviving infants were
re-examined at a central clinic at 9 months of age. Parents
were classified in five exposure groups as shown in Table II
and compared with regard to age, parity, economic status,
consanguinity, prevalence of syphilis, previous induced abor-
tion and degree of cooperation. The programme began in
stages from 1948 and was closed in January 1954 because of
the rapid reduction in the birth rate, when the only sugges-
tive evidence of variation in the direction expected from
genetic theory was the trend in the sex ratio (Neel et al.,
1953; Neel and Schull, 1956).
The somatic effects programme, by contrast, developed
piecemeal. It started by conducting surveys and, in the class-
ical clinical way, by selecting a relatively small group of
exposed survivors and arranging for them to have regular clinical examinations; the so-called Adult Medical Survey. Survivors were identified in a radiation census in 1949 and a
sample census carried out by the ABCC a year later but there
was, at that time, no prospect of obtaining estimates of dose
for individuals. Exposed survivors were, therefore, classified
according to their distance from the hypocentre at the time
of the explosion and the presence or absence of acute symp-
toms attributable to irradiation. The surveys quickly pro- vided conclusive evidence that irradiation increased the risk
of leukaemia (Folley et al., 1952), cataracts (Cogan et al., 1952) and mental retardation in children most proximally
exposed in utero (Plummer, 1952), but the plan for repeated
clinical examinations proved to be ill-conceived. By 1954, it
was seeking to examine regularly some 5000 people, who had
been exposed within 2000 m and had suffered symptoms
attributable to irradiation, and a control group of men and
women matched for sex and age, who had been exposed
beyond 2500 m, and it was foundering in the face of negative
findings and declining participation. There was, consequently,
thought of closing it down (Beebe, 1979).
Reaction to the hydrogen bomb test
Just then another event occurred that altered the perspective
of governments and their scientific advisers throughout the
world. In June 1954, a hydrogen bomb was exploded over
Eniwetok in the Pacific, which had 1000 times the power of
the Hiroshima and Nagasaki bombs, and radioactive fallout
Table II Classification of parents by exposure (after Neel and Schull, 1956)
Distancefrom hypocentre Shielding Symptoms, Group
Unexposed I
Over 3000 + or -
2000-2900 Some - 2
1500- 1900 Light or moderate -
Under 1500 Heavy
2000-2900 None -
1500- 1900 Light - 3
1000 -1400 Light or moderate -
Under 1000 Moderate -
1000- 1900 None - 4b
Under 1000 Light or none -
Under 3000 None or some + 5b
'Epilation, petechiae, gingivitis. bCategories 4 and 5 are usually combined.
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was distributed over the whole globe. Further test explosions
seemed certain to be carried out by competing powers and
determination of the quantitative effects of small doses of
radiation became a burning issue. National committees were
appointed in the UK and the US to review the evidence.
Their reports made it clear that no quantitative estimate of
the risks could then be made (Medical Research Council,
1956; National Academy of Sciences, 1956a) and an immense
amount of research was initiated. Epidemiology by this time
had been shown to be capable of contributing to knowledge
of the aetiology of non-infectious disease and radio-
epidemiology moved from the wings to the centre of the
stage.
Keith Cannan had by then become Chairman of the
Division of Medical Sciences at the National Academy of
Sciences and the ABCC was one of his responsibilities. He
quickly realised that the existing programmes were not going
to provide the information needed and he sought advice from
an ad hoc committee under the chairmanship of Thomas
Francis Jr. A unified plan was recommended to determine
the cause specific mortality of a cohort of some 100000
persons (subsequently increased to about 120000) who were
selected from nearly three times that number resident in
Hiroshima or Nagasaki at the time of the national census on
1 October 1950 and whose history of exposure was known
(Francis et al., 1955). This was immediately accepted and the
sample, with some minor modifications (Jablon et al., 1965;
Beebe et al., 1971) became the basis for the Life Span Study,
which is still continuing and has provided the principal
evidence on which our current knowledge of the long-term
effects of radiation is based. To it was added a mortality
study of 2800 individuals exposed in utero and non-exposed
controls (Kato, 1971) and the registration of all cases of
cancer, irrespective of the individual's subsequent survival
(Beebe and Hamilton, 1975) and research was begun to
enable tissue doses to be estimated for each member of the
cohort.
In the UK, a smaller study was instigated by the Medical
Research Council, with the specific purpose of determining
the quantitative relationship between X-ray dose and the
incidence of leukaemia (Medical Research Council, 1956;
Court Brown and Doll, 1957). Data were obtained for 14 000
patients who had been given radiotherapy for ankylosing
spondylitis and 1500 patients treated by other means and this
study has also been continued to the present day and
expanded to include mortality from all types of cancer and a
detailed assessment of the doses received in each major organ
(Weiss et al., 1994).
The contribution of modern radioepidemiology
In the years that followed, many other epidemiological
studies were carried out and more detailed information about
the qualitative and quantitative effects of ionising radiation
obtained than about any other noxious agent except, per-
haps, cigarette smoke, The literature has been reviewed
regularly by the United Nations Scientific Committee on the
Effects of Atomic Radiation (UNSCEAR) from 1958 to 1994
and the International Commission on Radiological Protec-
tion (most recently in 1990) and periodically by the US
National Research Council (most recently in 1988 and 1990)
and other similar bodies and it would be impossible to do
justice to it here. I shall, therefore, just summarise the risks
as I see them now and draw attention to the limits of their
reliability.
Four effects have been postulated from doses less than
those required to produce acute effects or macroscopic
damage to tissues, either on the basis of animal experiments
or from human experience: namely, the production of muta-
tions in germ cells leading to the development of congenital
anomalies or hereditary disease in offspring, congenital
defects from irradiation in utero, an increased rate of non-
specific ageing and an increased risk of cancer.
Genetic effects
That mutations would have been produced in the sperm and
ova of the survivors of the explosions was never doubted.
The risk was assumed to be proportional to the dose
received, when the dose was small enough not to produce
infertility, and damage to the world's genetic stock was long
thought to be the principal hazard of the fallout from the
atmospheric testing of nuclear weapons. In 1956, however,
the British Medical Research Council, in its report on the
hazards of nuclear radiation, could base its estimates of the
dose required to double the mutation rate in humans only on
the assumption that it was similar to that of the animals and
plants for which it had reliable information. It concluded
that the best estimate of the doubling dose was between 30
and 80 rads (0.3-0.8 Gy). Even the lowest estimate of 3 rads
(0.03 Gy) based on the assumption that all mutations were
normally caused by natural radiation, was not thought to be
contradicted conclusively by what had by then been found in
Japan.
More precise determination of the susceptibility of human
gonads to irradiation was, however, so important that the
ABCC initiated a fresh programme to obtain further data on
the trend in the sex ratio at birth with parental dose and to
compare the lifespan of children, one of whose parents had
been irradiated, with that of suitable controls. The first objec-
tive was attained by the end of 1962, by which time the sex
was known for over 140 000 children, 74000 of whom had
one or more exposed parents. The regression of the sex ratio
on dose was then found to be trivial and in the opposite
direction to that postulated (Schull et al., 1966) and no
further study of this effect seemed worthwhile.
The second objective was, in contrast, expanded to include
comparisons of cancer incidence, cytogenetic changes and
mutations altering the electrophoretic mobility or activity of
30 proteins and the initial findings have been reanalysed in
the light of the estimates of dose obtained in 1986. The
results of 40 years' observations were summarised by Neel
and Schull and their colleagues in 1990. No statistically
significant effects were seen with any of eight indicators. For
six of the indicators, the regressions on dose are summarised
in Table III. For three of them, the direction of the trend is
contrary to what would be expected from damage to parental
germ cells. The two other indicators were not being summ-
arised in the same way. One, balanced structural rearrange-
ment of chromosomes, showed a non-significant increase in
the prevalence of aberrations with increasing dose, but a
lower prevalence in children of all exposed parents (0.22%)
than in children ofcontrols (0.31%). No regression on paren-
tal dose was calculated, because it has not yet been possible
to separate with certainty the abnormalities inherited from
the parents from those that had arisen de novo in the germ
line. The other, the growth and development of the offspring,
is not amenable to similar quantitative analysis. So far,
measurements into school ages have not revealed any diff-
erences that could be related to parental exposure.
Estimation of doubling dose Not all these indicators are
likely to have an equal contribution from spontaneous muta-
Table III Regression on parental dose of six indicators of genetic
damage (after Neeljt al., 1990)
Regression on dose (Sv)
Indicator ± standard error
Untoward pregnancy outcome 0.00264 ± 0.00277
Mortality from non-malignant disease 0.00076 0.00154
Incidence of cancer under 20 years -0.00008 ± 0.00028
(most genetic subset) (- 0.00005 ± 0.00013)
Sex chromosome aneuploidy 0.00044 ± 0.0009
Mutation altering serum or -0.00001 ± 0.00001
blood protein
Offspring maleness 0.0027a± 0.0040
(mothers only)
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tion and Neel et al. (1990) calculate that the most probable
gametic doubling dose of acute low LET radiation is between
1.7 and 2.2 Gy. For low dose rate exposures, mouse
experiments suggest that the effect should be halved, leading
to a doubling dose of the order of 4 Gy or somewhat more
- 5 times the upper limit of the Medical Research Council's
estimate in 1956. This estimate does not take into account
the few observations of reciprocal translocations (which were
equal in the two populations) nor the sex ratio results (which
were counter to the genetic hypothesis) nor the data on
growth and development (which revealed no hint of a radia-
tion effect). If these other indicators could also be taken into
account, the estimate of the doubling dose would be in-
creased further.
Paternal radiation and childhood leukaemia The only mat-
erial challenge to this conclusion came from Gardner et al.
(1990) when they adduced evidence to suggest that paternal
irradiation in the course of employment at the nuclear rep-
rocessing plant in Sellafield was responsible for the small
cluster of young people with leukaemia that occurred in the
village of Seascale, 3 km south of the plant. Seven cases were
seen between 1955 and 1983, which was about ten times the
number expected. A case-control study of children born and
resident in the county found that the risk was concentrated in
children whose fathers had received substantial doses of
ionising radiation at work before the child's conception
(Table IV). Support for Gardner's idea came from studies in
which radiation histories (mostly of medical X-rays) had
been given by parents some years after the event and were,
therefore, liable to recall bias. Studies in which exposures had
been recorded objectively, as in Yoshimoto et al.'s (1990)
study of the children of Hiroshima and Nagasaki survivors
and in studies in Canada (McLaughlin et al., 1993), Scotland
(Kinlen et al., 1993) and the south of England (Roman et al.,
1993) have not shown any similar effect, nor has there been
any excess of childhood leukaemia in other parts of the
county in which Sellafield is situated, despite the fact that
92% of the births to Sellafield employees occurred outside
Seascale and the fathers had received 93% of the total
preconception dose (Parker et al., 1993). Childhood leuk-
aemia, moreover, seems seldom, if ever, to be a dominantly
inherited disease (Hawkins et al., 1995) and the size of the
effect postulated by Gardner et al. (1990) is biologically
implausible for such relatively small doses. Review of the
totality of the evidence leads to the conclusion that the
cluster was not due to chance, but that the association with
paternal irradiation largely or wholly was (Doll et al., 1994).
Future prospect Barring accidents, it seems unlikely that any
better estimate of the genetic risk is likely to be obtained
from any other human population and further precision can
be expected only from the genetics programme now being
undertaken by the Radiation Effects Research Foundation in
Hiroshima. This is intended to establish 1000 or so constella-
tions of lymphocytoid cell lines from fathers, mothers, and
children, half from exposed families and half from controls,
which can be examined for mutation of selected proteins.
Congenital defectsfrom irradiation in utero
Serious mental retardation The second effect, damage of the
developing embryo or fetus, has caused radiologists much
anxiety. That exposure of the abdomen of pregnant women
to doses or the order of200-500 mGy might cause the infant
to be born with a small head and to be mentally retarded
had long been suspected clinically, but was established by
observations on the survivors of the atomic bomb explosions.
A total of 1544 children born to women exposed during
pregnancy have been followed and 30 have been classed as
severely mentally retarded on clinical grounds. The prev-
alence in relation to dose and post-ovulatory age is shown in
Table V, after exclusion of three children with Down synd-
rome. The maximal effect was seen when exposure occurred
during the 8th- 15th week of pregnancy, when cortical
neurones are most actively produced. At this period some
effect was seen with doses down to 50mGy, but lack of
Table IV Relative risk ofleukaemia in young persons by father's occupational exposure
to ionizing radiation (after Gardner et al., 1990)
Father's dose No. ofcases 95%
before child's Leukaemic Area Relative Confidence
conception children controls risk limits
Total
0 38 253 1.00 -
1 -49 mSv 3 19 1.12 0.31-4.05
50-99 mSv I 11 0.69 0.08-5.73
> I0OmSv 4 5 6.24 1.51-25.76
Previous 6 months
0 38 262 1.0 -
I -4 mSv 3 18 1.30 0.32-5.34
5-9 mSv 1 3 3.54 0.32-38.88
10mSv 4 5 7.17 1.69-30.44
No dose 38 253 1.00
Any dose 8 35 1.71 0.68-4.26
Table V Prevalence of severe mental retardation in individuals exposed in uteroa (after
UNSCEAR, 1993)
Dose (Gy)
rost-ovutatory age <(0.01 0.01-0.09 0.10-0.49 0.50-0.99 > 1.0
(weeks) (0)" (0.05) (0.23) (0.64) (1.38)
8-15 2/255 2/44 1/57 3/15 9/12
(0.8%) (4.5%) (1.8%) (20.0%) (75.0%)
16-25 2/308 1/55 0/57 0/16 3/8
.(0.6%) (0.8%) (0.0%) (0.0%) (37.5%)
0-7 or > 26 4/504 0/102 0/92 0/10 0/6
(0.8%) (0.0%) (0.0%) (0.0%) (0.0%)
aThree individuals with Down syndrome excluded (doses 0 at 36 weeks, 0.29 Gy at 13
weeks and 0.56 Gy at 12 weeks). bMean uterine absorbed dose.
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knowledge of the mechanism by which mental retardation is
produced makes it difficult to know a priori what type of
dose-response relationship should be expected (UNSCEAR,
1993). From the 16th-25th week of pregnancy an effect was
seen only with doses greater than 1 Gy; at other periods no
effect was seen.
Intelligence test scores Intelligence test scores of children
not mentally retarded show a reduction which is similarly
limited to those exposed in the 8th-25th weeks of pregnancy
and is most marked in the 8th- 15th week. The results are
shown in Figure 1. Qualitatively, the findings are consistent
with the interpretation provided by UNSCEAR (1993) that
there is a dose-related shift in IQ that is large enough to
explain the increase in the number of children clinically
classified as mentally retarded.
Small head and seizures The only other effects to have been
observed in liveborn infants are a reduction in head size and
seizures. The latest analyses, which allow for normal varia-
tion, provide no reason to think that small heads were caused
after the 15th week of pregnancy. Before that period 12 were
associated with mental retardation and 18 were associated
with a generalised impairment of growth, which, unlike men-
tal retardation, also occurred with exposure in weeks 1-7
(Otake and Schull, 1993).
Seizures at 2 years of age or over, were related to dose
only when the child had been exposed in utero at a post
ovulatory age of 8-15 weeks. After exclusion of those
associated with severe mental retardation and those attrib-
utable to some extraneous cause, seizures (which occurred in
about 1% ofunexposed children) were also related to dose in
an apparently linear manner, without any statistical reason to
postulate a threshold (Dunn et al., 1990).
Total effects on development of brain The quantitative risk
of all these effects on the development of the brain, which are
plausibly related to dose in a linear way when exposure
occurs at 8-15 weeks, are summarised in Table VI. At
16-25 weeks the risks are much less and cannot be related to
dose at levels less than 0.5 Gy. Uncertainty about the
biological mechanisms and the absence ofappropriate human
data limit these findings to the effects of acute doses and
prohibit their extrapolation to doses given at low dose rates.
Abortion No other risk of congenital defect has been seen,
possibly because any dose large enough to produce such an
effect in the first 7 weeks also causes the embryo to be
aborted, as about half the embryos that were exposed to
0.5 Gy or more in this period were lost (Committee for the
Compilation of Material on Damage Caused by the Atomic
Bombs in Hiroshima and Nagasaki, 1981).
Non-specific ageing
The third effect, an increased rate of non-specific ageing, was
predicted on the basis of animal experiments in which
irradiated rodents experienced a shortening of life propor-
tional to dose with a 7% loss per LD50 (National Academy
of Sciences, 1956b). Within weeks, the idea spread round the
world that 1 rad led to the loss of expectation of about 10
days' life (4.7% shortening of life per 100 rad, Storer and
Sanders, 1958) and this, or something very similar, was sup-
ported when Warren (1956) reported that US radiologists
experienced a loss of 5.2 years oflife, or 11% of the adult life
span, in comparison with physicians with no known contact
with radiation. Both claims were, in fact, unjustified, being
based on a misuse of data for the average age at death. The
rodents suffered an increased age-specific mortality from
cancer that reduced their lifespan and consequently the age
at death from other causes, while Warren had not taken
account of the peculiar age distribution of radiologists that
allowed them to have the same mean age and a lower mean
age at death without having any higher mortality at any
given age. Subsequently, however, Seltser and Sartwell (1965)
0 0
0
0
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0-7 weeks 16-25 weeks All ages
8-15 weeks > 26 weeks
Post-ovulatory age
Figure I Mean IQ scores recorded in individuals exposed in
utero to the atomic explosions at Hiroshima and Nagasaki by
post-ovulatory age (United Nations Scientific Committee on the
Effects of Atomic Radiation, 1994; Schull et al., 1988). 0,
>0.01 Gy; 0, 0.01 -0.09 Gy; *, 0.1 -0.49 Gy; 0, >0.5 Gy; A,
0.5-0.99Gy; A, >1.OGy.
Table VI Quantitative risks ofdamage to fetal brain from irradiation
at post-ovulatory age 8-15 weeks (after UNSCEAR, 1993)
Damage Riskefrom Exposure to I Gy
Serious mental retardation Increased from 0.8% to 40%
IQ Loss of 25-30 per cent points
School performance 50th percentile reduced to 10th
percentile
Unprovoked seizure in absence Increased 25 times at ages
of serious mental retardation 2 years and over
'Risk linearly proportional to dose.
showed that the mortality of US radiologists was higher than
that of non-radiological physicians and higher still than that
of US ophthalmologists and ear-nose-throat specialists, both
from cancer and from other causes, and they concluded that
the results 'warrant the inference that occupational exposure
to ionizing radiation on the part of physicians has in the past
produced a non-specific life shortening effect'. British
radiologists, in contrast, were found to have a lower mor-
tality from causes other than cancer than other doctors and
other men in the same socioeconomic class, even if they
began practice before 1921 when stringent precautions
against exposure began to be taken (Smith and Doll, 1981).
No general life-shortening effect has been observed in the
major studies of radiation workers whose doses of radiation
have been measured (Cardis et al., 1995), nor in the Life
Span Study at doses less than 2 Gy (Shimizu et al., 1991).
The weight of the evidence, in my opinion, suggests that the
idea should be abandoned, unless some new experimental
evidence is obtained to revive it.
Risk ofcancer
The fourth effect, an increased risk of cancer, came gradually
to be accepted as due to one or more somatic mutations,
partly as a result of epidemiological observations in the mid
1950s (Court Brown and Doll, 1957; Lewis 1957) but even as
late as 1960 it continued to be resisted by some distinguished
radiobiologists (Brues, 1960). With acceptance of its muta-
tional origin, the risk of cancer displaced genetic effects as
the principal cause of public concern and the dose tolerated
for radiation workers and the general public has been pro-
gressively reduced. The principal quantitative evidence has
come from the Life Span Study, but it has been extended,
modified, and checked by the results of :biological exper-
iments and epidemiological studies of patients irradiated for
medical reasons, people exposed at work, children exposed tofallout from the testing of nuclear weapons and populations
exposed to different amounts of natural radiation by virtue
of their place of residence.
Radon in houses For a few risks the Life Span Study is of
no help, as it provides no information about the effects of
high linear energy transfer radiation or of any radionuclides
absorbed internally, the most important of which is the effect
of radon in house air.
That radon causes a risk of lung cancer roughly propor-
tional to dose and no material risk of any other type of
cancer is abundantly clear from 11 major studies of men
exposed to radon in mines (Lubin et al., 1995; Darby et al.,
1995). Extrapolation from the experience of miners is, how-
ever, fraught with difficulty, for the risk varies not only with
total exposure and dose rate but also, in a way specific for
lung cancer, with time since exposure occurred and in a
complex way with the amount smoked. If this were not
enough, there are the additional difficulties of extrapolating
from male miners who were exposed in adult life, to members
of the general public, who breathe less deeply, breathe air
that is less contaminated with dust, were exposed in child-
hood and include women. Temporary solutions have been
proposed by the US National Research Council (1991) and
Lubin et al. (1995) and the latter have used them to estimate
that the proportions of lung cancer deaths attributed to
domestic radon in the US are 10% in men and 12% in
women, less in smokers and rising to 28% and 31% respec-
tively in non-smokers. Lubin et al.'s (1995) formulae have
not yet been applied in Britain, but the proportions would be
likely to be about half those in the US, corresponding to the
lower mean concentration of the gas (arithmetic mean
20 Bq m-3 against 49 Bq m-3).
In these circumstances estimates of the effect of radon in
houses, which may vary 100-fold, need to be validated by
direct observations on people with and without lung cancer,
with known smoking habits and measured concentrations of
radon in their houses. Such studies, however, also have their
difficulties, including the need to measure concentrations in
past places of residence, which may have been pulled down
or altered, random errors in measurement and differences in
behaviour that affect the dose that individuals receive in a
given environment. So far seven such studies have been
reported, four of which have led to estimates of risk that are
not very different from those extrapolated from the
experience of miners (Schoenberg et al., 1990; Ruosteenoja,
1991; Pershagen et al., 1992), while three have not suggested
any risk at all (Blot et al., 1990; Alavanja et al., 1994;
Letourneau et al., 1994). Several others are in train and the
best estimate of risk should eventually be obtained from the
pooled results of the most reliable studies. If then we add on
the complexities of the model required to determine the dose
received by the cells capable of giving rise to lung (or rather
bronchial) cancer, it follows that these epidemiological obser-
vations can as yet tell us little or nothing about the quality
factor appropriate for alpha radiation. Nor can the much
fewer observations of the effect of the intake of radium on
the risk of bone sarcoma or of thorium on the risk of liver
cancer and leukaemia (National Research Council, 1988).
Irradiation offetus For another risk the evidence from the
Hiroshima and Nagasaki survivors and case-control studies
of affected patients is conflicting: namely, the risk of child-
hood cancer from irradiation in utero. Two children
developed cancer under 15 years of age out of 1263 exposed
to the bombs prenatally with less than one expected (0.73)
and the estimated excess per Gy was 0.5% with 95%
confidence limits of - 0.2% to 2.4%. Neither child had
leukaemia and the upper 95% confidence limit for this
disease was 1.1% per Gy (Yoshimoto et al., 1988). Both
these upper limits are substantially less than the excesses
expected to occur from the results of the case-control
studies, as estimated by the National Radiological Protection
Board (Muirhead et al., 1993). The results of the
case-control studies are, however, so consistent, based on
Hazards ofionising radiaton
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1: such large numbers, and shown not to be plausibly explained
by recall bias or confounding (Hewitt et al., 1966; Bithell and
Stewart, 1975; Monson and MacMahon, 1984; Mole, 1990)
that they cannot easily be dismissed. A causal explanation
for the observed relationship is, moreover, supported by the
evidence from the Oxford Survey of Childhood Cancers,
which shows that the risk increased with the number of films
to which the fetus was exposed in the last trimester of
intra-uterine life and declined compatibly with the temporal
decline in obstetric dose (Bithell, 1989). On detailed examina-
tion the various objections that have been made to a causal
explanation seem likely to be invalid (Doll and Wakeford,
1995) and the relatively small excess observed in children
exposed prenatally in Hiroshima and Nagasaki is best att-
ributed to an unusual effect ofchance. On this basis, the best
estimate of the risk of childhood cancer from irradiation in
utero is 6% per Gy and ofchildhood leukaemia 2.5% per Gy
(Muirhead et al., 1993), the last of which is only slightly
greater than that from exposure in early childhood (1.8% per
Gy).
External irradiation after birth For most ordinary
exposures, the results of the Life Span Study are pre-eminent.
Nearly 7000 deaths from cancer and over 8500 registered
cases have been observed in a population of some 76000
people with individually estimated doses, and the results have
led to the conclusion that the lifetime risk from fatal cancer
is about 10% per Sv with about a tenth of the deaths
attributable to leukaemia, that the risk is linearly propor-
tional to dose between about 0.2 and 4 Sv, and that linear
extrapolation to lower doses goes through or very close to
zero. On the basis of animal experiments it has usually been
assumed that extrapolation to the effects of doses below
0.2 Sv, and certainly to the effect of such doses given at low
dose rates, requires division by two (International Commis-
sion on Radiological Protection, 1990). It is now clear, how-
ever, that the analyses that led to these conclusions were too
simple.
Physically, it appears from measurements of specific
radionuclides in concrete and soil that the neutron doses at
distances greater than 1 km from the hypocentre of the exp-
losion over Hiroshima have been underestimated and this
may lead to a reduction in dose estimates by 10-20%
(Straume et al., 1992; UNSCEAR, 1994). Clinically, a review
of autopsy records suggests that the mortality attributed to
cancer has been underestimated, particularly in the older age
groups. While not affecting estimates of relative risk, this
suggests that absolute excess estimates need to be increased
by about 10% (Sposto et al., 1992) which largely cancels out
the error due to the underestimation of neutron dose.
Statistically, random errors in dose estimates lead to a
downward bias in the estimated risk per unit dose and may
also distort the shape of the dose-response curve, so as to
make an upward curvature approximate linearity. Different
methods have been used to estimate the effect of such errors.
A conservative estimate by Pierce et al. (1990) implies that
the risk estimates are too low: for solid cancers by 7-11%,
and for leukaemia by 4-7%. Statistical analysis, taking these
errors into account, shows that the dose-response relation-
ship for leukaemia is significantly better fitted by a linear
quadratic relationship than by a linear one and that the best
estimate of the factor by which the slope of a linear model
should be divided to give the slope at low doses is 2.2. There
is, however, no compelling statistical reason to abandon a
linear relationship for fatal cancers other than leukaemia, as
the best estimate of the comparable reducing factor is 1.3,
which is not significantly greater than 1 (Pierce and Vaeth,
1989, 1991).
It is the biological considerations, however, that are likely
to be the most important: in particular the possibility of
variation in susceptibility by sex, age, organ irradiated and
background risk. Variation by age is particularly important
as the excess relative risk has proved to be higher for
exposure in childhood and youth than at older ages and
determination of the attributable lifetime risk for cancersHazards of ionising radiation
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Table VII Estimate of lifetime risk of death from cancer other than leukaemia
following acute whole body exposure to radiation a(after UNSCEAR, 1994)
Assumptionforfuture Risk ofexposure induced death (%)
relative risk Following 0.2 Sv Following I Sv
Constant 2.4 10.9
Decline to excess risk at age 50 years 1.9 9.2
Decline to zero excess risk at age 1.6 7.5
90 years
apopulation with age distribution of Japan in 1985.
other than leukaemia depends crucially on whether the excess
relative risk remains constant throughout life for those
exposed in youth, as it has done approximately for those
exposed at older ages or whether it falls, as the cancer
incidence data suggest (Thompson et al., 1994). The impor-
tance of this is indicated in Table VII, which shows the
variation in the estimated lifetime risks of exposure-induced
death from cancers other than leukaemia from doses of 0.2
and 1.0 Sv depending on the trend in risk in young people
after 1987.
How far there is any variation in the susceptibility of
organs is unclear, apart from the greater susceptibility of the
marrow to the induction of myeloid and acute lymphatic
leukaemia and the reduced (even zero) susceptibility to
chronic lymphatic leukaemia. The excess relative risk per Sv
and its 90% confidence limits for 18 types of cancer, as
observed in the Life Span Study over the period 1958-87, is
shown in Figure 2. Nearly all the confidence limits overlap.
The high relative risk of breast cancer is not seen in
irradiated cohorts in western countries and may result from
the low normal risk ofbreast cancer in Japan. There appears,
however, to be a generally low relative risk for cervix cancer,
Hodgkin's disease, and possibly non-Hodgkin's lymphoma.
There is evidence too from several studies to suggest that the
temporal distribution of the risk varies by site, the risk of
lung cancer, for example, falling 20 years after exposure and
the risk of bladder cancer starting late and persisting longer.
It may consequently prove necessary to work out
dose-response relationships separately for each of the main
types of cancer.
The most important consideration may, however, prove to
be the variation in risk with the size of the background risk,
which may subsume much of the variation with sex. For it is
variation with background risk, or lack of it, that determines
the possibility of generalising observed risks from one
population to another. Hitherto it has been assumed that the
excess relative risk will be the same for all populations. The
current method may prove to be right for some cancers, but
for others it is almost certainly wrong. For lung cancer, for
example, the excess relative risk is much greater for females
than for males, and this may indicate that the interaction
with smoking is nearer additive than multiplicative, as has
been found in the studies of men exposed to radon in mines
and from in vitro studies of cell transformation (Piao et al.,
1990). If similar variation holds for other types of cancer, it
will vitiate the generalisation of site-specific risks.
Important though these qualifications are for estimating
the precise effect of a given dose in different situations, none
of them will, I think, modify our general conclusions about
the nature of the dose-response relationship. Nor, taken all
together, should they alter our estimate of the regression of
risk on dose by as much as 2-fold in either direction.
Effect ofvery small doses What then can we conclude about
the risks extrapolated down to the low doses of modern
radiography and nuclear medicine and the minute doses to
which we are continuously exposed from natural sources in
the environment and our own bodies? Epidemiology can take
us so far, but sooner or later we have to resort to a model
for quantification. Given a model, which it has been shown
fits human experience at moderate doses, epidemiology can
at least check that the risk extrapolated down to very low
doses has not been seriously underestimated. A model that
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Figure 2 Excess relative risk per Sv and 90% confidence limits
for 18 types of cancer observed in the Life Span Study of
survivors of the Hiroshima and Nagasaki explosions (1958-87)
(United Nations Scientific Committee on the Effects of Atomic
Radiation, 1994; Thompson et al., 1994).
results in a linear, or a linear quadratic, relationship with
dose without a threshold accords well with the effects
observed for doses of 100 mGy and above up to about 4 Gy,
when killing effects begin to distort the curve. In my own
view, which may not be widely shared, the observations on
the irradiated fetus justify extending the model down to
about lOmGy, but whether there is such an efficient repair
mechanism for damage to DNA or a reaction to stress that
greatly reduces the effect of tiny doses is something that
observations on humans are unable to decide.
So far as leukaemia is concerned, the evidence of the effect
of the accumulation of the tiny doses received in Utah from
the testing of nuclear weapons in Nevada (Stevens et al.,
1990) and of those received in the Nordic countries from the
testing of nuclear weapons worldwide (Darby et al., 1992)
shows that the current model does not seriously underes-
timate the effect and may even be thought to give it some
support. And if this is true of leukaemia it is likely also to be
true for other cancers caused by irradiation. If then we allow
that doses received at very low dose rates have only half the
effect that the dose-response relationship at high dose rates
would suggest, we can conclude that natural radiation in the
UK, other than radon, is responsible for about 1.4% of all
fatal cancers and that the effect of medical uses of ionising
radiation can be deduced pro rata, depending on the age of
the subject and his or her expectation of life.
Conclusion
In this review I have shown that clinical intuition served the
early exponents of Rontgen's discovery reasonably well. It
enabled them to detect the acute effects quickly, to recognise
the potential of X-rays to cause cancer in many tissues and
to control exposure so as to avoid aplasia of the marrow. It
failed to achieve consensus about the risk of leukaemia and
I(b)
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completely failed to recognise that the risk of cancer was
proportional to cumulative dose and that doses less than
those that caused gross mental retardation could damage the
fetal brain. Not surprisingly it failed to develop any sense of
the extent of the genetic hazard.
The development of epidemiology since the mid-century
has provided quantitative estimates of all these risks with
greater precision than is available for most other stochastic
effects. There remain some uncertainties, many of which are
capable of being cleared up within a few years. Precision in
the estimation ofvery small risks by epidemiological methods
is, however, a will-o'-the-wisp. Sooner or later we have to
resort to a model for quantification, which observations on
humans can help to define. Given a model, investigation of
the effect of very small doses can then ensure that the risk
extrapolated from higher doses is not substantially underes-
timated, and this I believe it has already done.
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